Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2019162585
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019162585
Title / Product Name
VERFAHREN ZUR VERBESSERUNG VON ASTHMASYMPTOMEN MIT BENRALIZUMAB
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2019162585
EP Publication Number
3536339
E-Number
1435664
Language
EN
PCT Number
Publication Date
11.09.2019 A
06.10.2021 B1
Registration Date
06.10.2021
AT Publication Date
15.10.2021
Application Date
07.08.2014
Registration Number
-
Priorities
12.08.2013
US
201361864950 P
IPC
A61K 39/00 20060101AFI20190704BHEP
Maximum Duration of Protection
07.08.2034
Owner
Astrazeneca AB
151 85 Södertälje
SE
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
WARD, Christine
MedImmune LLC One MedImmune Way
Gaithersburg, Maryland 20878
US
ROSKOS, Lorin
MedImmune LLC One MedImmune Way
Gaithersburg, Maryland 20878
US
WANG, Bing
MedImmune LLC One MedImmune Way
Gaithersburg, Maryland 20878
US
RAIBLE, Donald
317 Lenape Drive
Berwyn, Pennsylvania 19312
US
Information about Fees
Click here to load the fees